Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

Square Pharmaceuticals' Vice-Chairman Ratna Patra has announced plans to acquire 1.5 million shares of the company. This purchase is valued at approximately Tk33 crore at current market rates. Ratna, ...

MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Ajanta Pharma, Granules India, and Sun Pharmaceutical also traded with losses, ranging between 2% and 4%. Uncertainty surrounding the scale of US tariffs, the possibility of retaliatory measures ...

Tapan Chowdhury, managing director of Square Pharmaceuticals, announced his intention to acquire 1.5 million shares of the company, valued at over Tk32 crore at the current market price. Chowdhury, ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

Investing.com-- Sun Pharmaceutical (TADAWUL:2070) Industries Ltd. (NSE:SUN) said on Monday that it will buy Checkpoint Therapeutics Inc (NASDAQ:CKPT)- a Nasdaq-listed immunotherapy and oncology ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a U.S.-based immunotherapy and targeted oncology company, for $355 million. The deal is in line with Sun ...

Sun Pharma, the largest pharmaceutical company in India, issued one advisory on March 18 cautioning their CFAs and distributors about the rising menace of counterfeit and substandard medicines in the ...